Pharmacovigilance

A.1.5 – Pharmacovigilance notice

This website has not been designed to collect safety information related to Bristol Myers Squibb products.

Healthcare Professionals 

Reporting of suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Freepost, HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website:  www.hpra.ie; E-mail:  [email protected]

Adverse reactions should also be reported to Bristol Myers Squibb Medical Information on 1 800 749 749 or  [email protected]

Patients 

Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via Freepost, HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; E-mail: [email protected]. By reporting side effects you can help provide more information on the safety of this medicine.

Side effects should also be reported to Bristol Myers Squibb Medical Information on 1 800 749 749 or [email protected]

Healthcare professionals and patients should also report Product Quality Complaints to Bristol Myers Squibb Medical Information on 1 800 749 749 or [email protected]

NO-IE-2100034
Date of preparation: February 2021